Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment
Despite multimodal treatment, survival chances for high-risk neuroblastoma patients remain poor. Immunotherapeutic approaches focusing on the activation and/or modification of host immunity for eliminating tumor cells, such as chimeric antigen receptor (CAR) T cells, are currently in development, ho...
Main Authors: | Jennifer Frosch, Ilia Leontari, John Anderson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/7/1743 |
Similar Items
-
The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy
by: Gerard J. Chu, et al.
Published: (2019-12-01) -
Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
by: Xidan Gao, et al.
Published: (2021-02-01) -
Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer
by: Achyut BR, et al.
Published: (2016-03-01) -
Myeloid Cells in Glioblastoma Microenvironment
by: Alessandra De Leo, et al.
Published: (2021-12-01) -
Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy
by: Emile J. Clappaert, et al.
Published: (2018-10-01)